Table 1.
Main features of apoptosis, autophagy, cuproptosis, ferroptosis, necroptosis and pyroptosis.
Type of cell death | Morphological features | Biochemical features | Key regulators | Reference |
---|---|---|---|---|
Apoptosis | The permeability of cell membrane is enhanced, chromatin condensation, nuclear fragmentation, cell membrane blistering, cell shrinkage, the formation of apoptotic bodies | Pro-apoptotic BCL-2 protein family members, activation of caspases, oligonucleosomal DNA fragmentation | BCL-2, P53, Caspase, FAS, BAX, BAK, BCL-XL | [6, 7] |
Autophagy | Accumulation of autophagic vacuoles, vacuolisation of the cytoplasm, formation of double-membraned, autolysosomes, no chromatin condensation and lack of change in the plasma membrane | Conversion of LC3-I to LC3-II, Increase of lysosomal activity and degradation of P62 | ATG5, ATG7, Beclin 1, TFEB | [8, 9] |
Cuproptosis | Rupture of plasma membrane, other unknown | Copper accumulation, protein lipoylation | FDX1, LIAS, LIPT1, DLAT, GLS, MTF | [10, 11] |
Ferroptosis | Cell membrane rupture and vesicle, increase of cell membrane density, atrophy of mitochondria, reduction or even disappearance of mitochondrial ridge, chromatin condensation | Iron-overload, accumulation of ROS, Inhibition of system XC— and depletion of GSH, release of arachidonic acid mediators | SLC7A11, GPX4, P53, VDAC2/3, NRF2, LSH, TFR1, NOX | [3–5] |
Necroptosis | Rupture of plasma membrane, swelling of cytoplasmic, chromatin condensation(moderate) | Decrease in ATP level, activation of RIP1, RIP3, and MLKL, PARP1 hyperactivation and release of DAMPs | LEF1, RIP1/3, MLKL | [12, 13] |
Pyroptosis | Rupture of plasma membrane, karyopyknosis, cytoplasmic swelling and DNA breaks | Activation of caspase-1 and the release of inflammatory cytokines IL-1β and IL-18 | CASP1/4, IL-1, IL-18, GSDMD | [13, 14] |
BCL-2 B-cell lymphoma-2, BAX BCL2 associated X, apoptosis regulator, BAK BCL2 antagonist/killer 1, BCL-XL BCL2 like 1, ATG5 autophagy related gene 5, ATG7 autophagy related gene 7, TFEB transcription factor EB, FDX1 ferredoxin 1, LIAS lipoic acid synthetase, LIPT1 lipoyltransferase 1, DLAT dihydrolipoyl transacetylase, GLS glutaminase, MTF1 metal regulatory transcription factor 1, SLC7A11 solute carrier family 7 member 11, GPX4 glutathione peroxidase 4, VDAC2/3 voltage dependent anion channel 2/3, NRF2 nuclear factor erythroid 2-related factor 2, LSH lymphocyte stimulating hormone, TFR1 transferrin receptor, NOX NADPH oxidase, LEF1 lymphoid enhancer binding factor 1, RIP1/3 receptor interacting protein kinase1/3, MLKL mixed lineage kinase domain-like, CASP1/4 caspase 1/4, IL-1 interleukin-1, IL-18 interleukin-18, GSDMD Gasdermin D.